Combined Positive Score and Cisplatin Sensitivity Are Prognostic Factors for Response to Nivolumab Therapy for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck.
Iijima H, Sakai A, Ebisumoto K, Ogura G, Yamauchi M, Teramura T, Yamazaki A, Watanabe T, Inagi T, Yanagiya R, Yamamoto A, Ashida H, Ota Y, Sato Y, Kobayashi N, Maki D, Nakamura N, Okami K.
Iijima H, et al. Among authors: ota y.
Clin Med Insights Oncol. 2024 Oct 16;18:11795549241290030. doi: 10.1177/11795549241290030. eCollection 2024.
Clin Med Insights Oncol. 2024.
PMID: 39429682
Free PMC article.